{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:09:54Z","timestamp":1791497394293,"version":"4.3.4"},"reference-count":37,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CBM"],"published-print":{"date-parts":[[2020,7,3]]},"DOI":"10.3233\/cbm-201463","type":"journal-article","created":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T17:23:55Z","timestamp":1585070635000},"page":"397-408","source":"Crossref","is-referenced-by-count":19,"title":["Expression of cancer stem cell markers CD24, EPHA1 and CD9 and their correlation with clinical outcome in epithelial ovarian tumours"],"prefix":"10.1177","volume":"28","author":[{"given":"Rohit Pravin","family":"Nagare","sequence":"first","affiliation":[{"name":"Laboratory for Cancer Biology, Department of Medical Oncology and Clinical research, Cancer Institute (WIA), Chennai, Tamilnadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smarakan","family":"Sneha","sequence":"additional","affiliation":[{"name":"Laboratory for Cancer Biology, Department of Medical Oncology and Clinical research, Cancer Institute (WIA), Chennai, Tamilnadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chirukandath","family":"Sidhanth","sequence":"additional","affiliation":[{"name":"Laboratory for Cancer Biology, Department of Medical Oncology and Clinical research, Cancer Institute (WIA), Chennai, Tamilnadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Roopa","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Clinical Research, Cancer Institute (WIA), Chennai, Tamilnadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanchan","family":"Murhekar","sequence":"additional","affiliation":[{"name":"Department of Pathology, Cancer Institute (WIA), Chennai, Tamilnadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundersingh","family":"Shirley","sequence":"additional","affiliation":[{"name":"Department of Pathology, Cancer Institute (WIA), Chennai, Tamilnadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajaraman","family":"Swaminathan","sequence":"additional","affiliation":[{"name":"Division of Epidemiology and Cancer Registry, Cancer Institute (WIA), Chennai, Tamilnadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Velusamy","family":"Sridevi","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Cancer Institute (WIA), Chennai, Tamilnadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trivadi Sundaram","family":"Ganesan","sequence":"additional","affiliation":[{"name":"Laboratory for Cancer Biology, Department of Medical Oncology and Clinical research, Cancer Institute (WIA), Chennai, Tamilnadu, India"},{"name":"Department of Medical Oncology and Clinical Research, Cancer Institute (WIA), Chennai, Tamilnadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/CBM-201463_ref1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","article-title":"Stem cells, cancer, and cancer stem cells","volume":"414","author":"Reya","year":"2001","journal-title":"Nature"},{"key":"10.3233\/CBM-201463_ref2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nbt0109-44","article-title":"Looking ahead in cancer stem cell research","volume":"27","author":"Dick","year":"2009","journal-title":"Nature Biotechnology"},{"key":"10.3233\/CBM-201463_ref3","first-page":"728","article-title":"Ovarian cancer care: It\u2019s time for \u201cpersonalized\u201d approaches","volume":"24","author":"Aletti","year":"2010","journal-title":"Oncology"},{"key":"10.3233\/CBM-201463_ref4","doi-asserted-by":"crossref","first-page":"731","DOI":"10.4161\/cc.8.5.7848","article-title":"Epithelial ovarian cancer: focus on genetics and animal models","volume":"8","author":"Shan","year":"2009","journal-title":"Cell Cycle"},{"key":"10.3233\/CBM-201463_ref5","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1158\/0008-5472.CAN-08-0364","article-title":"Identification and characterization of ovarian cancer-initiating cells from primary human tumors","volume":"68","author":"Zhang","year":"2008","journal-title":"Cancer Research"},{"key":"10.3233\/CBM-201463_ref6","doi-asserted-by":"crossref","unstructured":"S. Zhang, B. Cui, H. Lai et al., Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy, Proceedings of the National Academy of Sciences 111 (2014), 17266\u201317271.","DOI":"10.1073\/pnas.1419599111"},{"key":"10.3233\/CBM-201463_ref7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/1574888X11666160607211436","article-title":"Cancer stem cells \u2013 are surface markers alone sufficient","volume":"12","author":"Nagare","year":"2017","journal-title":"Current Stem Cell Research & Therapy"},{"key":"10.3233\/CBM-201463_ref8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1476-5586(04)80047-2","article-title":"ONCOMINE: A cancer microarray database and integrated data-mining platform","volume":"6","author":"Rhodes","year":"2004","journal-title":"Neoplasia"},{"key":"10.3233\/CBM-201463_ref9","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The cancer genome atlas pan-cancer analysis project","volume":"45","author":"Weinstein","year":"2013","journal-title":"Nature Genetics"},{"key":"10.3233\/CBM-201463_ref10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/1875036201004010005","article-title":"Amazonia!: An online resource to google and visualize public human whole genome expression data","author":"Carrour","year":"2010","journal-title":"The Open Bioinformatics Journal"},{"key":"10.3233\/CBM-201463_ref11","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1074\/mcp.M500279-MCP200","article-title":"A human protein atlas for normal and cancer tissues based on antibody proteomics","volume":"4","author":"Uhlen","year":"2005","journal-title":"Molecular & Cellular Proteomics"},{"key":"10.3233\/CBM-201463_ref12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10147-016-1033-6","article-title":"Expression of a novel endothelial marker, C-type lectin 14A, in epithelial ovarian cancer and its prognostic significance","volume":"22","author":"Priya","year":"2017","journal-title":"International Journal of Clinical Oncology"},{"key":"10.3233\/CBM-201463_ref13","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ng.2653","article-title":"The genotype-tissue expression (GTEx) project","volume":"45","author":"Lonsdale","year":"2013","journal-title":"Nature Genetics"},{"key":"10.3233\/CBM-201463_ref14","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Research"},{"key":"10.3233\/CBM-201463_ref15","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1158\/1538-7445.AM2015-1392","article-title":"Abstract 1392: ALDH1A1 is the best marker by a composite approach for cancer stem cells in ovarian cancer whose integrity is controlled by the hedgehog pathway","volume":"75","author":"Nagare","year":"2015","journal-title":"Cancer Research"},{"key":"10.3233\/CBM-201463_ref16","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S1470-2045(08)70308-5","article-title":"The cell of origin of ovarian epithelial tumours","volume":"9","author":"Dubeau","year":"2008","journal-title":"The Lancet Oncology"},{"key":"10.3233\/CBM-201463_ref17","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00432-012-1334-8","article-title":"Systematic analysis and validation of differential gene expression in ovarian serous adenocarcinomas and normal ovary","volume":"139","author":"Bauerschlag","year":"2013","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"key":"10.3233\/CBM-201463_ref18","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0002-9440(10)64398-2","article-title":"CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival","volume":"161","author":"Kristiansen","year":"2002","journal-title":"Am J Pathol"},{"key":"10.3233\/CBM-201463_ref19","doi-asserted-by":"crossref","first-page":"e17617","DOI":"10.1371\/journal.pone.0017617","article-title":"Comparison of expression profiles in ovarian epithelium in vivo and ovarian cancer identifies novel candidate genes involved in disease pathogenesis","volume":"6","author":"Emmanuel","year":"2011","journal-title":"PLoS One"},{"key":"10.3233\/CBM-201463_ref20","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1158\/1535-7163.MCT-14-0607","article-title":"CD24+ ovarian cancer cells are enriched for cancer-initiating cells and dependent on JAK2 signaling for growth and metastasis","volume":"14","author":"Burgos-Ojeda","year":"2015","journal-title":"Molecular Cancer Therapeutics"},{"key":"10.3233\/CBM-201463_ref21","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1007\/s00018-012-1055-9","article-title":"CD24 controls Src\/STAT3 activity in human tumors","volume":"69","author":"Bretz","year":"2012","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10.3233\/CBM-201463_ref22","doi-asserted-by":"crossref","first-page":"5600","DOI":"10.1158\/0008-5472.CAN-11-3666","article-title":"CD24 is an effector of HIF-1-driven primary tumor growth and metastasis","volume":"72","author":"Thomas","year":"2012","journal-title":"Cancer Research"},{"key":"10.3233\/CBM-201463_ref23","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1634\/stemcells.2006-0352","article-title":"A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas","volume":"25","author":"Assou","year":"2007","journal-title":"Stem Cells"},{"key":"10.3233\/CBM-201463_ref24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.humpath.2016.08.005","article-title":"CD24 is highly useful in differentiating high-grade serous carcinoma from benign and malignant mesothelial cells","volume":"58","author":"Davidson","year":"2016","journal-title":"Human Pathology"},{"key":"10.3233\/CBM-201463_ref25","first-page":"2745","article-title":"CD24, COX-2, and p53 in epithelial ovarian cancer and its clinical significance","volume":"4","author":"Zhu","year":"2012","journal-title":"Frontiers in Biosciences"},{"key":"10.3233\/CBM-201463_ref26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.bbrc.2013.01.102","article-title":"CD24 ovary cancer cells exhibit an invasive mesenchymal phenotype","volume":"432","author":"Kang","year":"2013","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.3233\/CBM-201463_ref27","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1038\/onc.2010.35","article-title":"CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells","volume":"29","author":"Gao","year":"2010","journal-title":"Oncogene"},{"key":"10.3233\/CBM-201463_ref28","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1158\/1078-0432.CCR-11-2188","article-title":"Stem cell pathways contribute to clinical chemoresistance in ovarian cancer","volume":"18","author":"Steg","year":"2012","journal-title":"Clinical Cancer Research"},{"key":"10.3233\/CBM-201463_ref29","doi-asserted-by":"crossref","first-page":"16437","DOI":"10.18632\/oncotarget.4103","article-title":"Accumulation of ALDH1-positive cells after neoadjuvant chemotherapy predicts treatment resistance and prognosticates poor outcome in ovarian cancer","volume":"6","author":"Ayub","year":"2015","journal-title":"Oncotarget"},{"key":"10.3233\/CBM-201463_ref30","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3346\/jkms.2013.28.10.1443","article-title":"Expression and clinicopathological significance of CD9 in gastrointestinal stromal tumor","volume":"28","author":"Yang","year":"2013","journal-title":"Journal of Korean Medical Sciences"},{"key":"10.3233\/CBM-201463_ref31","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bbrc.2011.04.098","article-title":"Regulation of cancer stem cell properties by CD9 in human B-acute lymphoblastic leukemia","volume":"409","author":"Yamazaki","year":"2011","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.3233\/CBM-201463_ref32","doi-asserted-by":"crossref","first-page":"5614","DOI":"10.1038\/sj.onc.1203856","article-title":"Eph receptors and ephrin ligands: Embryogenesis to tumorigenesis","volume":"19","author":"Dodelet","year":"2000","journal-title":"Oncogene"},{"key":"10.3233\/CBM-201463_ref33","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1471-2407-6-144","article-title":"Over-expression of Eph and ephrin genes in advanced ovarian cancer: Ephrin gene expression correlates with shortened survival","volume":"6","author":"Herath","year":"2006","journal-title":"BMC Cancer"},{"key":"10.3233\/CBM-201463_ref34","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrc2806","article-title":"Eph receptors and ephrins in cancer: Bidirectional signalling and beyond","volume":"10","author":"Pasquale","year":"2010","journal-title":"Nature Reviews Cancer"},{"key":"10.3233\/CBM-201463_ref35","first-page":"4415","article-title":"Knockdown of EPHA1 using CRISPR\/CAS9 suppresses aggressive properties of ovarian cancer cells","volume":"37","author":"Cui","year":"2017","journal-title":"Anticancer Res"},{"key":"10.3233\/CBM-201463_ref36","first-page":"5409","article-title":"Decreased Eph receptorA1 expression is related to grade in ovarian serous carcinoma","volume":"17","author":"Jin","year":"2018","journal-title":"Molecular Medicine Reports"},{"key":"10.3233\/CBM-201463_ref37","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/modpathol.2008.188","article-title":"Downregulation of EphA1 in colorectal carcinomas correlates with invasion and metastasis","volume":"22","author":"Dong","year":"2009","journal-title":"Modern Pathology"}],"container-title":["Cancer Biomarkers"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/CBM-201463","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:07:38Z","timestamp":1777385258000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/CBM-201463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,3]]},"references-count":37,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/cbm-201463","relation":{},"ISSN":["1875-8592","1574-0153"],"issn-type":[{"value":"1875-8592","type":"electronic"},{"value":"1574-0153","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7,3]]}}}